• Home
  • Privacy Policy
  • Terms & Conditions
  • Thank you
Profit News Report
No Result
View All Result
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
No Result
View All Result
Profit News Report
No Result
View All Result
Home Editor's Pick

9 House Republicans defy Mike Johnson, join Dems to advance Obamacare extension vote

by
January 8, 2026
in Editor's Pick
0
9 House Republicans defy Mike Johnson, join Dems to advance Obamacare extension vote
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Nine House Republicans bucked their party leaders on Wednesday evening to advance a vote on a Democrat-led healthcare bill.

The nine GOP lawmakers’ support was key to pushing ahead on a vote to extend enhanced Obamacare subsidies that expired at the end of last year. A vote on the bill itself is now expected Thursday afternoon.

It’s a blow to Speaker Mike Johnson, R-La., who argued for weeks that the majority of House Republicans were opposed to extending the COVID-19 pandemic-era tax subsidies.

But a significant number of GOP moderates were frustrated that their party leaders in the House and Senate had done little to avert a price hike for millions of Americans’ insurance premiums. 

Four of them signed onto a discharge petition filed by House Minority Leader Hakeem Jeffries, D-N.Y., last month aimed at forcing a vote on extending the subsidies for three years over House GOP leaders’ objections.

A discharge petition is a mechanism for getting legislation considered on the House floor even if the majority’s leadership is opposed to it.

Those four lawmakers — Reps. Mike Lawler, R-N.Y., Brian Fitzpatrick, R-Pa., Rob Bresnahan, R-Pa., and Ryan Mackenzie, R-Pa. — were among the nine to vote for advancing Jeffries’ petition on Wednesday.

At the time, they criticized leadership in both parties for not working toward a bipartisan solution earlier and said they were left with little choice in the matter.

The other five lawmakers who voted to advance the petition were Reps. Nick LaLota, R-N.Y., Maria Salazar, R-Fla., David Valadao, R-Calif., Max Miller, R-Ohio, and Tom Kean Jr., R-N.J.

The bill is expected to pass the House on Thursday, but it is all but certain to die in the GOP-controlled Senate.

Similar legislation led by Senate Democrats failed to reach the necessary 60-vote threshold to advance in December.

The vast majority of Republicans believe that the subsidies are a COVID-era relic of a long-broken federal healthcare system. Conservatives argued that the relatively small percentage of Americans who rely on Obamacare meant that an extension would do little to ease rising health costs that people across the country are experiencing.

But a core group of moderates has been arguing that a failure to extend a reformed version of them would force millions of Americans to grapple with skyrocketing healthcare costs this year.

House Republicans passed a healthcare bill in mid-December aimed at lowering those costs for a broader swath of Americans, but that legislation has not been taken up in the Senate.

This post appeared first on FOX NEWS
Previous Post

Venezuelan oil shipments surge to US ports with heavy crude after Maduro capture

Next Post

Cruz demands impeachment of Boasberg and judge who sentenced Kavanaugh’s attempted assassin

Next Post
Cruz demands impeachment of Boasberg and judge who sentenced Kavanaugh’s attempted assassin

Cruz demands impeachment of Boasberg and judge who sentenced Kavanaugh’s attempted assassin

  • Trending
  • Comments
  • Latest
A look back at Biden’s Remarkable 50-year career in politics

A look back at Biden’s Remarkable 50-year career in politics

March 20, 2025
Trump’s Fed Criticism Sparks Investor Concerns

Trump’s Fed Criticism Sparks Investor Concerns

April 22, 2025
Fed’s Stagflation Warning Impacts Crypto Markets

Fed’s Stagflation Warning Impacts Crypto Markets

April 21, 2025
BNB Price Surge Leads Crypto Gains as Bitcoin Climbs

BNB Price Surge Leads Crypto Gains as Bitcoin Climbs

April 21, 2025
US stocks open in the red: S&P down 0.5%, Nasdaq slips around 1%

US stocks open in the red: S&P down 0.5%, Nasdaq slips around 1%

0
Nvidia Stock Tumbles on Earnings Anticipation and AI Rivalry

Nvidia Stock Tumbles on Earnings Anticipation and AI Rivalry

0
The dollar index continues to pull back to a new low

The dollar index continues to pull back to a new low

0
BNGO Stock: BioNano Genomics Analysis and Forecast

BNGO Stock: BioNano Genomics Analysis and Forecast

0
US stocks open in the red: S&P down 0.5%, Nasdaq slips around 1%

US stocks open in the red: S&P down 0.5%, Nasdaq slips around 1%

January 16, 2026
Bank of America Q4 beat estimates, but here’s why BAC stock may stay in red

Bank of America Q4 beat estimates, but here’s why BAC stock may stay in red

January 16, 2026
Copper, aluminum climb on supply worries, but Commerzbank sees setback risk

Copper, aluminum climb on supply worries, but Commerzbank sees setback risk

January 16, 2026
Why Nvidia stock is down over 2% today

Why Nvidia stock is down over 2% today

January 16, 2026

Recent News

US stocks open in the red: S&P down 0.5%, Nasdaq slips around 1%

US stocks open in the red: S&P down 0.5%, Nasdaq slips around 1%

January 16, 2026
Bank of America Q4 beat estimates, but here’s why BAC stock may stay in red

Bank of America Q4 beat estimates, but here’s why BAC stock may stay in red

January 16, 2026
Copper, aluminum climb on supply worries, but Commerzbank sees setback risk

Copper, aluminum climb on supply worries, but Commerzbank sees setback risk

January 16, 2026
Why Nvidia stock is down over 2% today

Why Nvidia stock is down over 2% today

January 16, 2026
  • Privacy Policy
  • Terms & Conditions
  • Privacy Policy
  • Terms & Conditions

Disclaimer: Profitnewsreport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2025 Profitnewsreport.com

No Result
View All Result
  • Home
  • Privacy Policy
  • Terms & Conditions
  • Thank you

Disclaimer: Profitnewsreport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2025 Profitnewsreport.com